Table 1 Characteristics of CPP patients and cancer patients. Norway, 2015-2017

CPP patients, n (% CPP patients without the cancer diagnosis)

Patients

7 461 (46.3%)

6 428 (43.9%)

15 802 (64.6%)

16 824 (69.3%)

19 897 (48.7%)

23 279 (56.5%)

89 691 (56.9%)

Year

2015

2 375 (47.2%)

2 055 (43.5%)

4 726 (63.0%)

5 109 (68.1%)

6 113 (51.1%)

7 487 (56.8%)

27 865 (56.9%)

2016

2 521 (45.8%)

2 143 (44.1%)

5 660 (65.6%)

5 935 (69.6%)

6 992 (47.6%)

7 785 (56.9%)

31 036 (57.0%)

2017

2 565 (45.9%)

2 230 (44.1%)

5 416 (65.0%)

5 780 (70.1%)

6 792 (47.6%)

8 007 (56.0%)

30 790 (56.7%)

Age group

Under 50

344 (78.5%)

294 (70.4%)

1 546 (83.4%)

1 772 (84.8%)

389 (70.2%)

8 511 (79.3%)

12 856 (80.1%)

50-59

838 (60.3%)

789 (50.6%)

2 480 (74.4%)

2 493 (78.2%)

2 841 (59.0%)

5 106 (52.5%)

14 547 (62.2%)

60-69

2 251 (45.3%)

1 989 (42.7%)

4 240 (62.9%)

4 088 (70.9%)

8 533 (51.3%)

4 888 (39.0%)

25 989 (52.8%)

70-79

2 778 (40.8%)

2 372 (39.0%)

4 816 (59.4%)

5 080 (65.7%)

6 720 (42.6%)

3 216 (40.9%)

24 982 (49.8%)

80-90

1 250 (42.2%)

984 (44.7%)

2 720 (56.9%)

3 391 (58.1%)

1 414 (35.1%)

1 558 (32.6%)

11 317 (48.5%)

Income

Low

1 567 (42.0%)

2 936 (41.9%)

2 573 (63.1%)

6 933 (66.0%)

2 208 (47.0%)

6 402 (52.6%)

22 619 (55.2%)

Medium

4 259 (44.6%)

2 838 (44.3%)

8 258 (63.4%)

7 563 (70.5%)

9 696 (46.1%)

11 117 (56.9%)

43 731 (56.1%)

High

1 635 (54.9%)

654 (51.1%)

4 971 (67.5%)

2 328 (75.2%)

7 993 (52.2%)

5 760 (60.3%)

23 341 (59.9%)

Education

Low

2 641 (42.5%)

2 553 (41.7%)

4 209 (65.2%)

5 312 (67.8%)

3 889 (45.9%)

5 132 (55.9%)

23 736 (55.6%)

Medium

3 683 (46.6%)

2 947 (43.1%)

7 759 (64.1%)

7 603 (68.3%)

10 108 (47.9%)

9 707 (53.1%)

41 807 (55.3%)

High

1 137 (54.4%)

928 (52.5%)

3 834 (65.0%)

3 909 (73.3%)

5 900 (51.8%)

8 440 (60.9%)

24 148 (60.7%)

Comorbidity

Low

5 118 (48.5%)

4 725 (45.7%)

13 020 (64.8%)

14 701 (69.7%)

17 868 (48.8%)

21 991 (56.9%)

77 423 (57.5%)

Medium

1 484 (41.9%)

1 235 (37.7%)

1 739 (62.8%)

1 403 (69.1%)

1 420 (46.8%)

833 (51.9%)

8 114 (52.3%)

High

859 (41.1%)

468 (41.7%)

1 043 (65.4%)

720 (61.4%)

609 (49.6%)

455 (49.2%)

4 154 (52.9%)

Travel time

Short

5 695 (47.0%)

5 052 (44.5%)

12 384 (64.9%)

13 417 (69.7%)

15 535 (49.4%)

19 024 (56.5%)

71 107 (57.3%)

Medium

1 018 (44.5%)

820 (40.1%)

2 052 (63.4%)

2 044 (66.4%)

2 646 (45.8%)

2 726 (58.6%)

11 306 (55.3%)

Long

747 (43.8%)

556 (43.7%)

1 366 (63.7%)

1 363 (69.8%)

1 714 (46.9%)

1 529 (53.6%)

7 275 (55.2%)

Hospital referral area ⋆

Min †

32.4%

29.8%

42.5%

48.1%

28.9%

36.8%

45.4%

Max †

66.2%

61.3%

83.2%

84.0%

59.5%

73.1%

69.4%

SD

8.4%

7.7%

10.9%

10.0%

6.9%

9.2%

5.9%

EQ ‡

2.0

2.1

2.0

1.7

2.1

2.0

1.5

Cancer patients, n (% cancer patients included in CPP)

Patients

5 076 (78.9%)

4 629 (77.9%)

6 836 (81.8%)

6 471 (79.8%)

15 864 (64.4%)

10 911 (92.7%)

49 787 (77.7%)

Year

2015

1 650 (73.8%)

1 543 (73.0%)

2 252 (77.2%)

2 131 (75.5%)

5 136 (55.2%)

3 609 (89.3%)

16 321 (72.0%)

2016

1 682 (80.8%)

1 531 (78.8%)

2 307 (83.5%)

2 207 (81.8%)

5 378 (67.6%)

3 549 (94.5%)

16 654 (79.8%)

2017

1 744 (82.0%)

1 555 (82.0%)

2 277 (84.7%)

2 133 (82.1%)

5 350 (69.9%)

3 753 (94.3%)

16 812 (81.3%)

Age group

Under 50

87 (85.1%)

105 (84.8%)

366 (69.9%)

382 (70.4%)

160 (71.3%)

1 886 (93.2%)

2 986 (85.7%)

50-59

396 (84.1%)

461 (84.4%)

752 (84.6%)

674 (80.7%)

1 667 (69.2%)

2 613 (92.9%)

6 563 (83.5%)

60-69

1 503 (81.5%)

1 376 (82.6%)

1 860 (84.4%)

1 434 (82.8%)

5 939 (69.7%)

3 207 (92.9%)

15 319 (79.9%)

70-79

2 039 (80.9%)

1 821 (79.5%)

2 350 (83.4%)

2 110 (82.5%)

5 920 (65.5%)

2 063 (92.2%)

16 303 (77.1%)

80-90

1 051 (69.0%)

866 (63.2%)

1 508 (77.7%)

1 871 (76.1%)

2 178 (42.4%)

1 142 (91.9%)

8 616 (67.8%)

Income

Low

1 257 (72.2%)

2 273 (74.7%)

1 204 (78.7%)

2 984 (79.0%)

2 047 (56.8%)

3 336 (91.0%)

13 101 (77.2%)

Medium

2 942 (80.2%)

1 985 (80.1%)

3 702 (81.8%)

2 777 (80.3%)

8 199 (63.8%)

5 136 (93.3%)

24 741 (77.7%)

High

877 (84.4%)

371 (86.3%)

1 930 (83.8%)

710 (81.4%)

5 618 (67.9%)

2 439 (93.8%)

11 945 (78.4%)

Education

Low

1 965 (77.3%)

1 978 (75.2%)

1 827 (80.1%)

2 181 (78.3%)

3 446 (61.0%)

2 473 (91.5%)

13 870 (76.0%)

Medium

2 474 (79.6%)

2 109 (79.6%)

3 393 (82.2%)

2 987 (80.7%)

8 000 (65.8%)

4 916 (92.7%)

23 879 (78.2%)

High

637 (81.5%)

542 (81.5%)

1 616 (82.9%)

1 303 (80.2%)

4 418 (64.4%)

3 522 (93.6%)

12 038 (78.8%)

Comorbidity

Low

3 243 (81.4%)

3 179 (80.7%)

5 519 (83.1%)

5 498 (81.0%)

13 813 (66.2%)

10 219 (92.8%)

41 471 (79.3%)

Medium

1 110 (77.7%)

1 009 (76.3%)

820 (78.9%)

584 (74.1%)

1 352 (55.9%)

434 (92.4%)

5 309 (72.9%)

High

723 (70.0%)

441 (61.9%)

497 (72.6%)

389 (71.5%)

699 (43.9%)

258 (89.5%)

3 007 (65.0%)

Travel time

Short

3 850 (78.4%)

3 620 (77.5%)

5 351 (81.2%)

5 129 (79.3%)

12 291 (64.0%)

8 915 (92.8%)

39 156 (77.6%)

Medium

708 (79.9%)

603 (81.3%)

900 (83.6%)

842 (81.5%)

2 202 (65.1%)

1 217 (92.8%)

6 472 (78.1%)

Long

518 (81.3%)

406 (77.1%)

585 (84.8%)

500 (82.2%)

1 371 (66.2%)

779 (91.1%)

4 159 (78.4%)

Hospital referral area ⋆

Min †

69.0%

67.6%

69.4%

67.2%

44.8%

82.6%

72.7%

Max †

87.7%

86.8%

89.9%

88.1%

74.6%

98.4%

84.5%

SD

5.5%

5.9%

5.1%

4.8%

8.5%

3.6%

3.8%

EQ ‡

1.3

1.3

1.3

1.3

1.7

1.2

1.2